Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-03-22

FDA Approved: LATANOPROST — Original Application (Somerset Therapeutics, LLC)

View source ↗

Summary

FDA approved the original application for latanoprost from Somerset Therapeutics, enabling a generic latanoprost ophthalmic solution for reducing intraocular pr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)

Snippet

ORIG AP for LATANOPROST (LATANOPROST)